These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
13. Resectable lung lesions malignancy assessment and cancer detection by ultra-deep sequencing of targeted gene mutations in plasma cell-free DNA. Peng M; Xie Y; Li X; Qian Y; Tu X; Yao X; Cheng F; Xu F; Kong D; He B; Liu C; Cao F; Yang H; Yu F; Xu C; Tian G J Med Genet; 2019 Oct; 56(10):647-653. PubMed ID: 30981987 [TBL] [Abstract][Full Text] [Related]
14. Analysis of Plasma Cell-Free DNA by Ultradeep Sequencing in Patients With Stages I to III Colorectal Cancer. Reinert T; Henriksen TV; Christensen E; Sharma S; Salari R; Sethi H; Knudsen M; Nordentoft I; Wu HT; Tin AS; Heilskov Rasmussen M; Vang S; Shchegrova S; Frydendahl Boll Johansen A; Srinivasan R; Assaf Z; Balcioglu M; Olson A; Dashner S; Hafez D; Navarro S; Goel S; Rabinowitz M; Billings P; Sigurjonsson S; Dyrskjøt L; Swenerton R; Aleshin A; Laurberg S; Husted Madsen A; Kannerup AS; Stribolt K; Palmelund Krag S; Iversen LH; Gotschalck Sunesen K; Lin CJ; Zimmermann BG; Lindbjerg Andersen C JAMA Oncol; 2019 Aug; 5(8):1124-1131. PubMed ID: 31070691 [TBL] [Abstract][Full Text] [Related]
15. Plasma-Derived Cell-Free DNA as a Biomarker for Early Detection, Prognostication, and Personalized Treatment of Urothelial Carcinoma. Bhalla S; Passarelli R; Biswas A; De S; Ghodoussipour S J Clin Med; 2024 Apr; 13(7):. PubMed ID: 38610824 [TBL] [Abstract][Full Text] [Related]
16. Tumor-Agnostic Circulating Tumor DNA Testing for Monitoring Muscle-Invasive Bladder Cancer. Carrasco R; Ingelmo-Torres M; Trullas R; Roldán FL; Rodríguez-Carunchio L; Juez L; Sureda J; Alcaraz A; Mengual L; Izquierdo L Int J Mol Sci; 2023 Nov; 24(23):. PubMed ID: 38068899 [TBL] [Abstract][Full Text] [Related]
17. Circulating tumor DNA predicts neoadjuvant immunotherapy efficacy and recurrence-free survival in surgical non-small cell lung cancer patients. Yue D; Liu W; Chen C; Zhang T; Ma Y; Cui L; Gu Y; Bei T; Zhao X; Zhang B; Bai Y; Romero A; Xu-Welliver M; Wang C; Zhang Z; Zhang B Transl Lung Cancer Res; 2022 Feb; 11(2):263-276. PubMed ID: 35280315 [TBL] [Abstract][Full Text] [Related]
18. Patient-specific targeted analysis of circulating tumour DNA in plasma is feasible and may be a potential biomarker in UTUC. Mu N; Jylhä C; Axelsson T; Sydén F; Brehmer M; Tham E World J Urol; 2023 Dec; 41(12):3421-3427. PubMed ID: 37721600 [TBL] [Abstract][Full Text] [Related]
19. Analysis of ctDNA to predict prognosis and monitor treatment responses in metastatic pancreatic cancer patients. Cheng H; Liu C; Jiang J; Luo G; Lu Y; Jin K; Guo M; Zhang Z; Xu J; Liu L; Ni Q; Yu X Int J Cancer; 2017 May; 140(10):2344-2350. PubMed ID: 28205231 [TBL] [Abstract][Full Text] [Related]
20. A Review of Circulating Tumor DNA in the Diagnosis and Monitoring of Esophageal Cancer. Min J; Zhou H; Jiang S; Yu H Med Sci Monit; 2022 Feb; 28():e934106. PubMed ID: 35210388 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]